XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Investment in DSM Semichem LLC | 9 Months Ended
--- | ---
Sep. 30, 2025
Schedule of Investments [Abstract] |
Investment in DSM Semichem LLC | INVESTMENT IN DSM SEMICHEM LLC On October 19, 2022, Martin ELSA Investment LLC, the Partnership's affiliate, entered into definitive agreements with Samsung C&T America, Inc. and Dongjin USA, Inc., an affiliate of Dongjin Semichem Co., Ltd., to form DSM Semichem LLC (“DSM”). DSM will produce and distribute electronic level sulfuric acid (“ELSA”). By leveraging the Partnership's existing assets located in Plainview, Texas and installing additional facilities (the “ELSA Facility”) as required, DSM will produce ELSA that meets the strict quality standards required by the recent advances in semiconductor manufacturing. In addition to owning a 10% non-controlling interest in DSM, the Partnership will be the exclusive provider of feedstock to the ELSA Facility. The Partnership, through its affiliate MTI, will also provide land transportation services for the ELSA produced by DSM. On April 1, 2024, the Partnership contributed $6,500 in cash to DSM, which represents the cash contributions required pursuant to DSM's limited liability agreement for the Partnership's 10% non-controlling interest. Also, in conjunction with the formation of DSM, we contributed approximately 22 acres of land. The Partnership recognizes its 10% interest in DSM as "Investment in DSM Semichem LLC" on its Consolidated and Condensed Balance Sheets. The Partnership accounts for its ownership interest in DSM under the equity method of accounting. Selected financial information for DSM is as follows:
| As of September 30, |  | Three Months Ended September 30,
| Total Assets |  | Long-Term Debt |  | Members' Equity/Partners' Capital |  | Revenues |  | Net Income (Loss)
2025 |  |  |  |  |  |  |  |  |
DSM Semichem LLC | $ | 105,590 |  |  | $ | 28,530 |  |  | $ | 60,710 |  |  | $— |  | $195
| As of December 31, |  | Three Months Ended September 30,
| Total Assets |  | Long-Term Debt |  | Members' Equity/Partners' Capital |  | Revenues |  | Net Income (Loss)
2024 |  |  |  |  |  |  |  |  |
DSM Semichem LLC | $ | 105,773 |  |  | $ | 31,700 |  |  | $ | 68,513 |  |  | $— |  | $(1,369)
| As of September 30, |  | Nine Months Ended September 30,
| Total Assets |  | Long-Term Debt |  | Members' Equity/Partners' Capital |  | Revenues |  | Net Income (Loss)
2025 |  |  |  |  |  |  |  |  |
DSM Semichem LLC | $ | 105,590 |  |  | $ | 28,530 |  |  | $ | 60,710 |  |  | $— |  | $(7,804)
| As of December 31, |  | Nine Months Ended September 30,
| Total Assets |  | Long-Term Debt |  | Members' Equity/Partners' Capital |  | Revenues |  | Net Income (Loss)
2024 |  |  |  |  |  |  |  |  |
DSM Semichem LLC | $ | 105,773 |  |  | $ | 31,700 |  |  | $ | 68,513 |  |  | $— |  | $(3,249)

X
- Definition The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group. + References Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 323 -Publisher FASB -URI https://asc.fasb.org/323/tableOfContent + Details
Name: | us-gaap_EquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ScheduleOfInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration